The Board of Director of Mercury Laboratories Limited meeting held on 11 November, 2022, approved Creation of new facility for manufacturing Small Volume Parenteral(SVPs) having capacity of manufacturing of 75 Million Nos. of units annually at Unit No 2 at Baroda ­ Halol Road, Jarodiapura, Jarod with an estimated cost of INR 300 million. Its existing plant of Small Volume Parenteral(SVPs) is situated at Unit 1 Gorwa with the existing capacity of manufacturing of 24 Million Nos of units annually The above project is planned to go on stream in 36 months from zero date.

The Project when implemented, will contribute approx. INR 180 million yearly in sales of the Company at the prevailing market prices. The cost of the said project will be funded from internal accruals/surplus generated from internal operations and need based gap, if any, will be met from borrowings or Rupee Term Loans.

Rationales of the Project: To meet with Internal as well as external Regulatory market requirement, national as well as international by introducing New technologies for new development and opportunity in business. This capacity addition by the company will help to cater growing demand.